期刊
TUMOR BIOLOGY
卷 37, 期 6, 页码 8249-8258出版社
SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-015-4639-9
关键词
LKB1; AMPK; TGF-beta production and signaling; Breast cancer cell migration; Epithelial-to-mesenchymal transition
类别
资金
- National Nature Science Foundation of China [81171952, 81272926, 81460374, 31460304]
- NIH [R21EY024388]
- Nanchang University
Adenosine monophosphate-activated protein kinase (AMPK) acts as a fuel gauge that maintains energy homeostasis in both normal and cancerous cells, and has emerged as a tumor suppressor. The present study aims to delineate the functional relationship between AMPK and transforming growth factor beta (TGF-beta). Our results showed that expression of liver kinase B1 (LKB1), an upstream kinase of AMPK, impeded TGF-beta-induced Smad phosphorylation and their transcriptional activity in breast cancer cells, whereas knockdown of LKB1 or AMPK alpha 1 subunit by short hairpin RNA (shRNA) enhanced the effect of TGF-beta. Furthermore, AMPK activation reduced the promoter activity of TGF-beta 1. In accordance, type 2 diabetic patients taking metformin displayed a trend of reduction of serum TGF-beta 1, as compared with those without metformin. A significant reduction of serum TGF-beta 1 was found in mice after treatment with metformin. These results suggest that AMPK inhibits the transcription of TGF-beta 1, leading to reduction of its concentration in serum. Finally, metformin suppressed epithelial-to-mesenchymal transition of mammary epithelial cells. Taken together, our study demonstrates that AMPK exerts multiple actions on TGF-beta signaling and supports that AMPK can serve as a therapeutic drug target for breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据